The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 90 (high attention) · dilution pressure elevated · listing risk low · governance risk high · runway 2.6 mo · strongest signal: Insider selling before raise (Aug 13, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (runway < 6 months) coexists with live selling machinery (shelf filed). Base case is a discounted raise; the question is when, not if.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 13, 2026 | ▼ Insider selling before raise | 2 insider open-market sale(s) in the 45 days before financing filing on 2026-08-12: Lin Shao-Lee 34,[email protected] 2026-08-12; Lin Shao-Lee 5,[email protected] 2026-08-12 filing | 67 |
| Aug 13, 2026 | ▼ Insider selling cluster | 5 open-market sales by 1 insider(s) (~$1,606,562) in 30d filing | 45 |
| Aug 12, 2026 | ▼ Shelf filed | S-3 filed 2026-08-12 filing | 30 |
| Aug 3, 2026 | ▼ Departure cluster | 4 Item 5.02 8-Ks in 90 days (latest 2026-08-03) filing | 64 |
| Aug 3, 2026 | · Officer/director change | 8-K Item 5.02 filed 2026-08-03 (accepted 16:47 ET) filing | 22 |
| Jun 30, 2026 | ▼ Runway < 6 months | ~2.6 months runway: liquidity $17,392,000 as of 2026-06-30, burn $81,001,611/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing | 44 |
| Jun 30, 2026 | ▼ Share count +25% | Shares outstanding 4,045,701 (2026-05-12) -> 7,264,414 (2026-08-12), +80% filing | 37 |
VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →